Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of NANOG, in particular, by targeting natural antisense polynucleotides of NANOG. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of NANOG.
Information query
Patent Agency Ranking
0/0